Background: Practical improvements are needed to allow measurement of glucose concentrations by Fouriertransform infrared (FT-IR) spectroscopy. We developed a new method that allows determination of the glucose concentration in dried sera. Methods: We studied 32 serum samples after fourfold dilution and desiccation before FT-IR analyses on a spectrometer operated at a resolution of 2.0 cm ؊1 . We integrated all spectral windows at the surface of the spectrum in the COO region. For comparison, glucose was measured in the sera by a glucose oxidase method. Results: One peak within the spectrum was most specific for glucose (997-1062 cm ؊1 ). Its surface integration showed a strong relationship with reference data (r ‫؍‬ 0.998; P <0.001). FT-IR analyses of five glucose solutions were performed to determine its specific absorption at the same peak. In this way, glucose concentrations in serum spectra could be measured. For the first time while using FT-IR spectroscopy, no manipulation of spectra nor use of internal standard was necessary to obtain results in high accordance with glucose concentration measured by a conventional (glucose-oxidase) method (S yͦx ‫؍‬ 0.25 mmol/L; r ‫؍‬ 0.998). Conclusions: FT-IR spectroscopy appears to be an easy and accurate method to determine glucose concentration and could be widely used to simultaneously identify and quantify several metabolites in biological fluids or tissues.
The search for a simple and accurate analytical method to determine glucose concentration is a problem of major importance for clinical laboratories. Most physicochemical analytical methods, such as Raman spectroscopy (1, 2 ) , mass spectrometry (3 ) , and nuclear magnetic resonance spectroscopy (4, 5 ) , have been evaluated as tools to determine glucose concentration in whole blood, plasma, or serum. With Fourier-transform infrared (FT-IR) spectroscopy, the spectrum of any molecule shows its characteristic absorptions. For glucose, the following absorption bands may be found: (OOH) between 3570 and 3120 cm Ϫ1 , (ACOH) between 3085 and 3020 cm Ϫ1 , (COO) between 1230 and 1000 cm Ϫ1 , and (COOOC) between 1275 and 800 cm Ϫ1 (6 ) . The two latter bands, the COO region, are known to be the most specific of this molecule in complex spectra (7, 8 ) .
When using this technique to determine glucose concentration, some corrections of results are still necessary, such as normalizations and/or standardizations of spectra. Ward et al. (9 ) obtained accurate results in using partial least-squares (PLS) calibration but determined that these were only reliable for single subjects. A standard calibration could not be proposed, probably because of differences in water IR absorption or protein content between samples. The normalization of each baseline set at zero absorbance is another methodological problem. Ward et al. (8 ) added glucose as an internal standard in the blood samples of diabetic subjects and applied PLS calibration to measure glucose concentrations. Several biases appeared, such as the effects of temperature on the water IR absorption in the solution sample, protein IR absorptions in the frequency range of analysis (between 950 and 1200 cm Ϫ1 ), and differences in blood composition specific to each subject.
In another experimental FT-IR method, Budinova et al. (10 ) deposited whole blood or serum samples on polyethylene cards and added KSCN as internal standard for peak absorbance comparisons. They analyzed dried samples and obtained accurate results with the 900-1185 cm Ϫ1 spectral area integration and with respect to the baseline. The method yielded reproducible results, but this fre-quency range is not specific for glucose absorption, which appears but is not alone between 900 and 1300 cm Ϫ1 . Furthermore, the use of an internal standard is still necessary to estimate glucose concentration. Heise and Bittner (11 ) concluded in similar experimentations that each manipulation of the spectrum has to be considered as a source of quantitative error affecting the prediction performances of the method used. Recently, Shaw et al. (12 ) obtained glucose concentration in accord with a reference clinical method using multivariate calibrations and statistical methods (PLS calibration), but an internal standard (KSCN) was still necessary because of the difficulty to obtain a reproducible dried-sample thickness onto the IR-transparent material. They had also to normalize their spectra (to a common absorption intensity in the C'N stretching mode of the KSCN internal standard). Although their normalized spectra provided equal or better agreement in all analyses, the differences were significant for glucose measurement. The normalization step was still necessary and provided a marked improvement in comparison with nonnormalized spectra.
Thus, practical improvements are still necessary to measure glucose concentration with a minimum of sample manipulations. The objective is the specific measurement of glucose absorption while avoiding any use of statistical normalization or internal calibration. To propose such a method, (a) we sought an appropriate dilution to obtain the highest spectral signal-to-noise ratio; (b) we investigated the most specific peak of glucose in serum spectra; (c) we measured glucose absorption at this peak with known glucose standards; (d) we used the results to calculate glucose concentration; and (e) we validated the method by comparison of our results with results of a glucose-oxidase method.
Materials and Methods subjects and sample collections
Blood samples from 32 diabetic patients were used for this study. The mean age of the patients was 49.9 Ϯ 15.8 years (range, 22-82 years). Sampling was done between 0730 and 0830, after an overnight fast of 10 h. Blood samples for glucose concentration determination were taken in two collection tubes (red top, Vacutainer; Becton Dickinson), one for the FT-IR method, and the other one for the enzymatic glucose oxidase method (13 ) . Venous blood was sampled with an antecubital venipuncture of the right arm using a Teflon catheter and was immediately centrifuged for 10 min at 4000g. Samples for FT-IR analyses were then stored at Ϫ20°C before analysis.
analyses After the samples returned to room temperature (ϳ15 min at 20 -25°C), aliquots of 15, 20, and 25 L were taken with a micropipette (pipetman P20; Gilson) and diluted with 85, 80, and 75 L, respectively, of water (pipetman P200; Gilson). SDs for the micropipette sampling volumes were 0.6% (0.12 L) for the P20 and 0.9% (0.73 L) for the P200 for 20 and 80 L, respectively, of water. The diluted samples were homogenized with an agitator (Vortex Reax 2000; Heidolf) at 1000g for 10 s. Then, 35 L of each solution was deposited exactly within the cell limits of a zinc-selenide (ZnSe) wheel bearing 15 sample cells (Bruker). Cell limits are materialized by a colored circle (interior diameter, 7 mm) that the sample must touch but not cover. The wheel was subsequently placed in a drying vacuum to evaporate water (45 min). A KBr cover was then screwed onto the wheel to protect it. The wheel was finally put into the analysis compartment of a Bruker IFS 28/B spectrometer equipped with a Globar (MIR) source (7 V), a KBr beamsplitter, and a DTGS/B detector (18 -28°C). For all experiments, we used a resolution of 2.0 cm Ϫ1 , and acquisitions were performed using 32 scans. Beam diameter at the sample location was 6 mm. All analyses were performed in triplicate on three successive wheels. The higher signal-to-noise ratio (731 Ϯ 25) and homogeneous baselines between samples were obtained using a 1:4 (vol/vol) serum dilution in water. The signalto-noise ratio was only 325 Ϯ 71 and 461 Ϯ 101, respectively, with 15:100 and 1:3 dilutions. The between-run CV was also the lowest (1.5%) for triplicate FT-IR measurements using the fourfold concentration of dilution. This was used for the following experiments.
calculations
The spectral integrations of Budinova et al. (10 ) avoided baseline variations, and this presents a particular interest for the interpretation of spectral data. They integrated the area between the spectral window and the cord running through the abscissa limits of the spectrum in the chosen frequency range (950 -1850 cm Ϫ1 ). We applied this method to integrate all of the spectral windows found at the surface of the spectrum in the COO region ( Fig. 1 ). This was done by the software Opus-Ident 2.2 (Bruker) after we had chosen the abscissa limits. Comparisons were made between the integration results (expressed in The area integrated for each peak is above the cord running through the two side points found at the surface of the spectrum after the abscissa limits have been chosen.
the Opus-Ident 2.2 software integration units; U) and the glucose concentration reference values.
spectral determination of glucose concentrations
For spectral discrimination between glucose and other hexoses that could be present in blood in nonnegligible concentrations, we performed the FT-IR analyses of 55 mmol/L solutions of d-fructose, d-galactose, and d-mannose ( Fig. 2) . To measure glucose absorption, we did the FT-IR analyses of five glucose solutions in water (S1 to S5) containing 6.77, 5.44, 4.11, 2.76, and 1.38 mmol/L (Ϯ10 Ϫ2 mmol/L), respectively, of d-glucose. This calibration series allowed measurement of the relative absorption of each glucose peak in the 1300 -900 cm Ϫ1 region. To avoid an eventual crystallization of the d-glucose during drying, which is a potential source of error for an optical technique such as FT-IR spectroscopy, we also used solutions of 20 L serum and 80 L of each glucose solution. When the above calibrators were diluted with 20% serum, the final glucose concentrations in this unique serum increased by 5.44, 4.33, 3.27, 2.22, and 1.11 mmol/L (Ϯ10 Ϫ2 mmol/L), and these later solutions were named S6 to S10. Glucose absorbances in these solutions were determined by subtracting the spectral area at peak 5 (997-1062 cm Ϫ1 ) of the serum diluted in water to the one diluted in a glucose solution. Therefore, the added d-glucose may be considered as an internal standard, as in the study by Ward et al. (8 ) . Glucose absorptions were then expressed in concentrations per spectrometer integration digits:
statistics Data are expressed as mean Ϯ SD. Linear regressions were done for comparison of series of data. Reference and spectral data were considered to be comparable when correlation coefficients (r) obtained a probability of P Ͻ0.01. When the data were comparable, dispersion data around regression lines were estimated by the mean prediction errors (S y͉x ) and the variation coefficient (VC, in percentages or standard units) around the regression line. Lastly, for differences between the methods, a standard t-test for paired data was done.
Results

clinical data
Subjects presented venous glucose concentrations of 11.15 Ϯ 6.94 mmol/L. Six subjects had glucose concentrations Ͻ2.5 mmol/L, and six others had glucose concentrations Ͼ19.5 mmol/L. The range was 1.83-23.14 mmol/L. This high heterogeneity was chosen for best comparison with FT-IR analyses.
comparisons of enzymatic and ft-ir analyses
There were five principal peaks in the COO region of a serum spectrum (Fig. 1 ). Comparisons between reference glucose concentrations and FT-IR absorbance areas of the peaks observed in the COO region are presented in Table  1 . The mean glucose concentration was 11.2 Ϯ 6.9 mmol/L with the glucose oxidase method and 0.31 Ϯ 0.19 U with FT-IR spectroscopy under peak 5 (997-1062 cm Ϫ1 ). The correlation between these data was r ϭ 0.998, P Ͻ0.001. The other peaks observed in the COO region showed a lower correlation between spectral and biochemical results, with P Ͻ0.05. Spectra were performed in triplicate; a high reproducibility was obtained with a mean difference of 1.76% (0.013 U) between FT-IR absorbance areas at the peak located between 997 and 1062 cm Ϫ1 . This mean difference was not statistically significant.
glucose determination and measurement
Spectra of the four hexoses analyzed did not show similar peaks in the COO region, in particular for glucose, which presents a strong absorption band at 1033 cm Ϫ1 , the only one found in this location (Fig. 2) . Fig. 3 presents the spectra of a serum (glucose concentrations, 5.5 mmol/L) diluted in water (1:4, by volume) and the same serum diluted in a 11 mmol/L glucose solution (1:4, by volume). The peak located at 1033 cm Ϫ1 presents the major increase Standard solutions (55 Ϯ 0.1 mmol/L) were used. The peak located at 1033 cm Ϫ1 is the most specific for glucose. of absorbance in the COO region because of the added glucose. Changes in the 997-1062 cm Ϫ1 absorption band with glucose concentration in aqueous solutions (S1-S5) and recovery of glucose in serum samples using the same absorption band (S6 -S10) are presented in Tables 2 and 3 , respectively. The mean glucose absorption per unit of spectral area at peak 5 (997-1062 cm Ϫ1 ) was 7.27 Ϯ 0.17 mmol ⅐ L Ϫ1 ⅐ U Ϫ1 for the glucose solutions and 7.26 Ϯ 0.11 mmol ⅐ L Ϫ1 ⅐ U Ϫ1 for the glucose solutions within sera. The correlation between the two series of calibrators was r ϭ 0.997 (P Ͻ0.001). The mean prediction error (S y͉x ) of these measurements was 0.09 mmol/L for glucose concentrations in calibrator solutions and 0.11 mmol/L when glucose was added to the sera. We subsequently used this value of 7.27 mmol ⅐ L Ϫ1 ⅐ U Ϫ1 to determine directly each glucose concentration by integrating the peak 5 area within the samples analyzed previously (and considering the 20% dilution chosen for analyses). Values with these methods were very close (11.15 Ϯ 6.94 mmol/L vs 11.14 Ϯ 6.98 mmol/L, respectively, for reference and FT-IR methods). The correlation between these data was r ϭ 0.998 (P Ͻ0.001) with a mean prediction error S y͉x ϭ 0.25 mmol/L (VC ϭ 0.14%). Regression between both methods is presented in Fig. 4 . Regression was very close to the expected relationship with a slope of 1.006 Ϯ 0.004 and an intercept of Ϫ0.049 Ϯ 0.003 mmol/L.
Discussion
The objective of this study was the specific and accurate measurement of glucose concentration using FT-IR spec-troscopy. The following original steps were performed: (a) focus on the most specific peak of glucose in the COO region; (b) quantification of glucose absorption under this peak with known calibrators; and (c) glucose concentration measurement without spectral manipulations.
Until now, several studies had been performed on sera in which different substances, such as d-glucose (8, 9 ) or  KSCN (10, 12 ) , were added. These two components behave as internal standards and thus may limit the method for routine measurements, because they require precise sample manipulations. Therefore, in our method, we tried to minimize manipulations, which actually consist of only one simple, fourfold dilution and drying the samples on the analysis wheel. The chemical composition of the blood samples and their differences were not altered. In contrast, Ward et al. (8 ) could not control glucose absorption with their method, because their calibration was done with wide-ranging absorptions of glucose in the spectrum and not its specific absorption in a definite band. Their calibration, performed on the basis of internal standards and general spectral absorptions, also contained other variables, i.e., proteins and water. Simple transmittance measurements of liquid blood or blood serum are impossible in the mid-IR because of the major absorption of water in the matrix (10 ), and wide absorption areas will necessarily take proteins into account because these are major blood or serum constituents (12 ) . Finally, the results of Ward et al. (8 ) were reliable only for single subjects, and they were not able to propose a standard method for routine measurements. The drying of the samples is of particular importance for this kind of technique because it avoids the standardization difficulties experienced by Ward et al. (8, 9 ) and by Heise and Bittner (14 ) , who analyzed samples in solution. The latter could not control the effects of water absorption in spectra and of room temperature on water.
Like Budinova et al. (10 ) , we analyzed dried samples to be free of any kind of interaction with changes in ambient conditions. However, they dried whole blood or blood sera in the ambient conditions of their laboratory. For whole blood, a time-dependent glycolysis is known to occur when erythrocytes and serum are not separated, which makes their method invalid for such samples. For blood sera, the drying probably lasted several hours, which represents a limitation when compared with clinical reference methods. Furthermore, an internal standard (KSCN) was still necessary because of the thickness variability of the samples applied on polyethylene cards. Fig. 3 . Spectra of a serum diluted in water and diluted in a glucose solution (11 mmol/L).
The peak located at 1033 cm Ϫ1 is the major IR glucose absorbance in the COO region (900 -1300 cm Ϫ1 ). Budinova et al. (10 ) integrated a large part of the COO region (900 -1185 cm Ϫ1 ) and Shaw et al. (12 ) chose the 925-1250 cm Ϫ1 region, which are too wide to be strongly specific for glucose. We expected to find a spectral peak more specific of glucose than these large regions. Actually, we found a statistically significant relationship (P Ͻ0.05) with the reference data for all peaks of the COO region and a strong relationship (P Ͻ0.001) for that located at 1033 cm Ϫ1 (997-1062 cm Ϫ1 ). This is in agreement with observations reported by Ward et al. (8 ) , who observed the strongest glucose absorbance at 1035 cm Ϫ1 . However, other blood hexoses are present at nonnegligible concentrations. To verify whether the peak located at 1033 cm Ϫ1 could be glucose specific, we also analyzed fructose, galactose, and mannose with the same method of analysis. The spectra of these derivatives are close to that of glucose. However, there were differences in the absorption frequencies. In comparison with the glucose peak located at 1033 cm Ϫ1 , fructose presents a peak at 1059 cm Ϫ1 , galactose at 1064 cm Ϫ1 , and mannose at 1075 cm Ϫ1 . Thus, our data suggest that the peak situated between 997 and 1062 cm Ϫ1 might correspond to a more specific absorption of the (COOOC) bond.
The second aim of the study was the quantification of the glucose absorption on this peak, which was done with a five-calibrator series. We found that glucose absorption per unit of spectral area was 7.27 mmol/L/U. This value was used to determine glucose concentration in serum spectra.
The strong relationship observed with the reference method (P Ͻ0.001) demonstrated that FT-IR spectroscopy is a clinically satisfactory method. Unlike Shaw et al. (12 ) , we obtained a standard error between reference and FT-IR methods (0.24 and 0.27 mmol/L, respectively), which allows our method to be more suitable for clinical routine measurements on diabetic subjects or other patients with metabolic disorders. It is possible that this very small difference from the reference method is because of the sample thickness we found highly reproducible. This thickness was so reproducible because of the high concentration of dilution used (1:4, by volume). It is, therefore, possible that the serum constituents were more evenly distributed onto the sample location than the one obtained by Shaw et al. Current enzymatic methods require frequent calibration controls and reagents, and this is very costly (15 ) . Our method does not require any reagent. Nevertheless, a longitudinal study in clinical conditions is necessary to assess the practical advantages of such an analysis. Moreover, other blood component concentrations could be determined during the same analysis or later because of the computerized preservation of spectral information. Furthermore, the ZnSe holder simultaneously allows 15 analyses, which represents a clear advantage in comparison with other instruments. It is conceivable that an extension of the wheel would allow the simultaneous analysis of more samples, and this could reduce proportionally the mean time and cost of analysis.
In conclusion, FT-IR spectroscopy allows accurate glucose concentration determination. Actually, it could be used for the simultaneous determination and quantification of a large variety of metabolites present in biological fluids. An important development of the method could be the determination of such derivatives from microsamples, which could combine the clinical accuracy of the measurements with the convenience of microsampling. Developments are under way in our laboratory to achieve such improvements. a ␦ peak 5 area ϭ difference between absorbance of the serum diluted in a glucose solution minus absorbance of the serum diluted in water. Glucose absorption is calculated by dividing its concentration by the spectral area obtained after integration at peak 5; n ϭ 32.
